Patients with Chronic Insomnia Get Relief by Taking Only Half of Their Medication

Nowadays, many people use different prescription medications to get relief from chronic insomnia. Based on the latest reports, new developments in this area will help them take only a half of their regular dose and even include placebos into a treatment plan. These studies offer a contrast to standard treatments and medications prescribed to people with this condition.

These findings can considerably reduce a number of tablets taken by patients to have a good rest at night. Moreover, this approach can boost their clinical benefits while reducing adverse effects and saving on their prescription expenses.

Chronic insomnia is a medical condition that makes patients unable to remain asleep or fall asleep with ease. They can’t keep relying on sleeping pills and their effects, because their long-term use may result in such negative outcomes as dependence and side effects, like nausea and drowsiness. This research is meant to change the existing industry standards and allow patients to switch to other drugs and reduce their amount.

This study covers more than 70 adult patients with chronic insomnia. They all were divided into a few groups and given different doses. Most of them informed that the effectiveness of staying and falling asleep of their medications remained the same. That’s why authors claim that their findings can encourage consumers to switch to lower doses and include placeboes into their treatment plans. The main reason is that full doses are not always needed to reach the necessary effect.

It’s concluded that getting the same effect of sleeping pills over a long period of time can be achieved by taking lower doses. For example, Ambien is often prescribed in 10 mg, but this study confirms that even 5 mg are enough to achieve the necessary effect. The best part is that users will experience fewer side effects while falling asleep easily.

In this study, the use of placebo is really amazing, because this practice is definitely more efficient than standard treatment plans for chronic insomnia. Its effect improves the expectancy of patients and the results of taking sleeping pills, too. This technique makes their intake more effective in the long run.

Based on the facts stated above, authors of this research claim that enough data will be obtained very soon to prove that these effects are possible. This information will help people understand that they need to take less medication as their maintenance therapy if they have chronic insomnia. In addition, authors will also keep advocating for using placebos in such treatment plans. When they are combined with lower doses of standard sleeping pills, they bring the same effectiveness to provide patients with an ability to sleep well at night while stopping experiencing unwanted side effects and other relevant problems. This study is very helpful, because there are many people who have this condition and need to take drugs regularly.